Upcoming Special Issue: Prevailing and imminent approaches in tumor, inflammation and fibrosis specific drug delivery
Experimental papers and reviews welcome
Recent progress in novel drug delivery technology has triggered the development of site-specific drug carriers and gained wide acknowledgment in contemporary therapeutics. This emerging paradigm in targeted drug delivery provides a promising approach to eradicating various incurable diseases like tumors, inflammation and fibrosis.
The present issue provides a comprehensive overview of the potential of various delivery systems, viz., lipoplexes, liposomes, polyplexes, nanoparticles and so forth to selectively relocate therapeutic drug moiety into specific cell type via the receptor-mediated endocytosis.
Nano Reviews is indexed in PubMed.
- Atul Pathak, Dr. Reddy’s Laboratories Ltd, India.
- Yoshiyuki Morishita, Jichi Medical University, Japan
How to submit:
Please go to the journal website at http://www.nano-reviews.net, read the author instructions carefully, click the “Submit a manuscript” button in the upper right-hand corner and follow the instructions. Select “Special Issue: Prevailing and imminent approaches respectively.”
All submissions are due by January 31, 2017.
Regular publication fee applies.